Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
CN |
|
Global Cannabis Applications Corp
OTC:FUAPF
|
CA |
|
L
|
Lepu Scientech Medical Technology Shanghai Co Ltd
HKEX:2291
|
CN |
|
Hutchison Telecommunications Hong Kong Holdings Ltd
HKEX:215
|
HK |
|
Bank7 Corp
NASDAQ:BSVN
|
US |
|
N
|
NanoString Technologies Inc
OTC:NSTGQ
|
US |
|
Nitori Holdings Co Ltd
OTC:NCLTF
|
JP |
|
H
|
Hanjin Heavy Ind & Const Holdings Co Ltd
KRX:003480
|
KR |
|
Amarjothi Spinning Mills Ltd
BSE:521097
|
IN |
|
Redwoods Acquisition Corp
NASDAQ:WENA
|
US |
|
I
|
I Power Solutions India Ltd
BSE:512405
|
IN |
|
K
|
K2 F&B Holdings Ltd
HKEX:2108
|
SG |
Dividends
Dividend Yield
Hebei Changshan Biochemical Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hebei Changshan Biochemical Pharmaceutical Co Ltd
Hebei Changshan Biochemical Pharmaceutical Co Ltd have
decreased
by 0%.
Payout Ratio
Hebei Changshan Biochemical Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Hebei Changshan Biochemical Pharmaceutical Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Hebei Changshan Biochemical Pharmaceutical Co Ltd
| Average Annual Return | 42.89% |
| Standard Deviation of Annual Returns | 67.15% |
| Max Drawdown | -50% |
| Market Capitalization | 37.7B CNY |
| Shares Outstanding | 919 060 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Hebei Changshan Biochemical Pharmaceutical Co Ltd's latest stock split occurred on Apr 20, 2016
The company executed a 18-for-10 stock split, meaning that for every 10 shares held, investors received 18 new shares.
Before the split, Hebei Changshan Biochemical Pharmaceutical Co Ltd traded at 15.85 per share. Afterward, the share price was about 8.1489.
The adjusted shares began trading on Apr 20, 2016. This was Hebei Changshan Biochemical Pharmaceutical Co Ltd's 3rd stock split, following the previous one in Apr 30, 2015.
